A physics- and spatially informed diffusion model accelerates Monte Carlo–level dose estimation for CyberKnife radiotherapy using planning CT and anatomical data.
Key Details
- 1The PSIDMViT model integrates planning CT, finite-size pencil beam dose distributions, and distance maps for dose prediction.
- 2Tested retrospectively in 251 CyberKnife patients (117 head-and-neck, 76 lung, 58 liver).
- 3Achieved 3D Gamma passing rates of 98.0% for head-and-neck, 94.0% for lung, and 95.0% for liver cases (1%/1 mm/10% criterion).
- 4Reduced dose computation time from about 1 hour to 18 minutes per plan versus Monte Carlo methods.
- 5Outperformed conventional finite-size pencil beam and baseline deep-learning models in accuracy.
- 6External and multi-institutional validation remains needed.
Why It Matters
Fast, Monte Carlo–consistent dose prediction can make accurate, individualized radiotherapy planning more feasible in clinical routine, improving workflow efficiency for high-precision treatments. This approach illustrates how integrating imaging, physics, and AI can address major clinical bottlenecks.
Source
EurekAlert
Related News
•EurekAlert
New G-AUDIT Tool Detects Hidden Bias in Medical AI Training Data
Johns Hopkins and FDA researchers unveil G-AUDIT, a tool to identify hidden biases in medical AI datasets before model training.
•EurekAlert
AI-Driven Bone Marrow Mapping Tool Improves Blood Cancer Assessment
Weill Cornell Medicine develops an AI tool to score and track disease severity in blood cancer from bone marrow imaging.
•EurekAlert
AI-Assisted Imaging Advances Precision in Brain Tumor Therapy Delivery
An AI-guided method improves intra-arterial therapy by mapping all tumor-feeding arteries to enhance delivery accuracy in malignant brain tumor treatment.